Collegium Pharma (COLL) Reports Q4 Loss of $1.02/Share

Collegium Pharma (NASDAQ: COLL) reported Q4 EPS of ($1.02), versus ($0.46) reported last year.

For earnings history and earnings-related data on Collegium Pharma (COLL) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
• Isabella Bank added to Russell 2000 index after Nasdaq listing